FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hy... (sense or appropriately respond to thirst...)

HOME >> MEDICINE >> NEWS

FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia

Date:5/21/2009

sense or appropriately respond to thirst, hypovolemic hyponatremia, concomitant use of strong CYP 3A inhibitors, anuric patients

Too Rapid Correction of Serum Sodium Can Cause Serious Neurologic Sequelae - During initiation and after titration monitor patients to assess serum sodium concentrations and neurologic status. Subjects with SIADH or very low baseline serum sodium concentrations may be at greater risk for too-rapid correction of serum sodium. In patients receiving SAMSCA who develop too rapid a rise in serum sodium, discontinue or interrupt treatment with SAMSCA and consider administration of hypotonic fluid. Fluid restriction during the first 24 hours with SAMSCA may increase the likelihood of overly-rapid correction of serum sodium, and should generally be avoided.

Gastrointestinal Bleeding in Patients with Cirrhosis - Used only when the need to treat outweighs this risk

Dehydration and Hypovolemia - In patients who develop medically significant signs or symptoms of hypovolemia, discontinuation is recommended. Dehydration and hypovolemia can occur, especially in potentially volume-depleted patients receiving diuretics or those who are fluid restricted.
Co-administration with Hypertonic Saline - Not recommended
Other Drugs Affecting Exposure to SAMSCA -
- CYP 3A Inhibitors - Do not use with strong inhibitors of CYP 3A; avoid concomitant use with moderate CYP 3A inhibitors
- CYP 3A Inducers - Avoid concomitant use with CYP 3A inducers. If co-administered, the dose of SAMSCA may need to be increased
- P-gp Inhibitors - The dose of SAMSCA may have to be reduced if co-administered with P-gp inhibitors
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.; Otsuka America Pharmaceutical, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9
Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine

Post Your Comments:

(Date:5/21/2013)... 2013 Global Proving Ground (GPG), a ... largest online retailer of health and fitness supplements, are ... show, Warrior Island. “We cast the show by ... Twitter, with our unique social networking platform,” states show’s ... fighters on an island in the Pacific Ocean, where ...

(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...

(Date:5/21/2013)... Department of Defense Serum Repository (DoDSR), University of Cincinnati ... inflammatory bowel disease (IBD), which could help with earlier ... shown symptoms. , This finding, the first of its ... being presented via podium presentation by staff from Walter ... 2013, being held May 18-21 in Orlando, Fla. ...

(Date:5/21/2013)... New York (PRWEB) May 21, 2013 ... surgery robot lawsuit is nearing its conclusion in ... to Bloomberg.com, during closing statements yesterday, an attorney for ... alleging the company wanted to tie sales and services ... all the training to keep control of surgeons, to ...

(Date:5/21/2013)... (PRWEB) May 21, 2013 Go Classy ... today that they have redesigned their website featuring ... beach, pool, hot tubs, bars and dining. The website, ... resort including sales and guest reviews, will now have ... Jamaica itself, including pages on culinary local recipes, flora ...

Breaking Medicine News(10 mins):Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 2 Health News:Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island 3 Health News:Researchers find genetic risk factor for pulmonary fibrosis 2 Health News:Biomarkers discovered for inflammatory bowel disease 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3 Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4 Health News:The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography 2

[0] Bodybuilding.com Partners with Global Proving Ground’s New Reality Show Warrior Island [0] Researchers find genetic risk factor for pulmonary fibrosis [0] Biomarkers discovered for inflammatory bowel disease [0] Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial [0] The Oldest and Original Nudist Travel Agency for NResort Announced Today a Redesigned Website Featuring Information on Culinary Events, Flora and Fauna, and Photography

... Cancer Patients in HELIOS HospitalsBERLIN, March 10 ... gain access to the most modern radiotherapy treatments with ... is acquiring nine linear accelerators from Varian Medical Systems ... equipped with RapidArc(TM) technology for fast and comfortable treatments. ...

... awareness for children and adults with autismFAIRFIELD, Conn. ... Network ( www.AutismSupportNetwork.com ) and the Israeli Society ... announced an international alliance to help foster support ... autism spectrum disorder (ASD). The partnership provides for ...

... March 10 More physician leaders are embracing technological ... consider them clunky and unresponsive to their needs.Those are ... American College of Physician Executives (ACPE). The findings were ... Journal, ACPE,s journal of medical management.ACPE conducted the same ...

... HOUSTON, March 10 InPlace Medical Solutions ... pioneering telemedicine healthcare services for Scorpion Offshore ... ongoing pilot project makes Scorpion Offshore the ... with the full-service system of advanced healthcare, ...

... /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS ... of the Company, will present at the Cowen and Company ... Place, on Wednesday, March 18, 2009 at 11:00 a.m. ET. ... presentation by visiting the "Events" section of the homepage of ...

... Quarter Adjusted FIFO EBITDA Increases 4.3% to $26.1 Million, ... Full Year Adjusted FIFO EBITDA Increases 15% to ... Year Net Cash Provided by Operating Activities Increases 130% ... $17.4 Million and Full Year Net Loss of $72.8 ...

Leading German Healthcare Group Selects Equipment and Software from Varian Medical Systems for Major Replacement Project Autism Support Network and the Israeli Society for Autistic Children Form International Alliance Survey Results: Health Care Technology Advances as Physician Frustration Grows Scorpion Offshore Inc. Pilot Project With InPlace Medical Solutions Sets New Standard for Offshore Medical Services Labopharm to present at Cowen 29th Annual Health Care Conference Duane Reade Holdings, Inc. Reports Fourth Quarter and Full Year 2008 Results

(Date:5/21/2013)... Regulus Therapeutics Inc . ( NASDAQ: RGLS ... of innovative medicines targeting microRNAs, today announced that ... Officer and Executive Vice President, Finance, will present a ... Conference on Wednesday, May 29, 2013 at 3:30 pm ... Boston Waterfront Hotel. The presentation will be ...

(Date:5/21/2013)... , May 21, 2013 On ... impressive new product developments at the Special Libraries Association PHTD ... of unerring focus on product literature databases and workflow solutions ... the occasion," said founding director Nigel Johnson ... of benefit to our clients and what better forum to ...

(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...

Breaking Medicine Technology:Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 2 Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia 3 Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2

[0] Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference [0] Pi2 Solutions' 10th Anniversary Heralds New Corporate Image as Platinum Sponsor of SLA PHT Meeting in Philadelphia [0] Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace

... CARY, N.C., Dec. 18 Cornerstone Therapeutics Inc. (Nasdaq CM: ... commercializing significant products primarily for the respiratory and related markets, ... 8:30 AM ET on Thursday, January 7, 2010, to discuss ... a press release outlining its financial guidance for 2010 prior ...

... , BOSTON, Dec. 18 Solos Endoscopy, Inc. (Pink Sheets: ... a significant design improvement to its MammoView(TM) ductoscope. In January ... stainless steel tip with a much stronger braided polyimide tip. ... made to our ductoscope. One of the major difficulties in ...

Cached Medicine Technology:Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 2 Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 3 Solos Endoscopy, Inc. Makes Significant Design Improvement To Its MammoView(TM) Ductoscope 2

Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010 Solos Endoscopy, Inc. Makes Significant Design Improvement To Its MammoView(TM) Ductoscope

... Intersurgical Incorporated manufactures high ... and moisture exchangers, ventilator ... hand-held nebulizers and an ... and connectors for anesthesia ...

... The Ulti-Mist™ HME product line has the ... pediatrics to adults and from intubated patients ... superior humidification for both anesthesia and critical ... HME/Filters provide maximum protection for patients and ...

... hygroscopic condenser humidifiers (HCH) capture the patient`s ... in the inspired gas. Small and compact, ... and hygroscopic benefits. Depending on the tidal ... small-volume model., ,The adult HCH is ...

Medicine Products:

Filta-Therm® with Integrated Y-piece and Flextube Patient Connection Filta-Therm® with Flextube Patient Connection Medisize Ulti-Mist HME/F Humidaire I And Omniflex Connector